Aditya Birla Nuvo Limited has informed the Exchange that the ESOS Compensation Committee of the Board of Directors of the Company has approved grant of 11,952 Stock Options (Tranche IV) to the eligible employees of the Company under ESOS-2006, each option being convertible into one equity share of the Company upon vesting, at an exercise price of Rs.697/- per option. The same is subject to the Securities and Exchange Board of India (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999 and the terms of the ESOS-2006 and the options will vest in 4 equal annual installments after one year of the grant and shall be exercisable within a period of 5 years form the date of vesting.

Ajmera Realty & Infra India Limited has informed the Exchange that the Register of Members and Share Transfer Book will be closed from September 23, 2010 to September 29, 2010 (both days inclusive) for the Purpose of Dividend and the Annual General Meeting of the Company scheduled for September 29, 2010.

	Allied Resins And Chemicals Limited has submitted to the Exchange a copy of the Notice of the Annual General Meeting of the members of the company to be held on September 29, 2010.
Attachment

	Alstom Projects India Limited has informed the Exchange regarding a press release dated September 09, 2010 , titled "Alstom to provide 168 cars for Chennai's metro for Euro 243 million (approx. INR 1470 crore)".
Attachment

Short Description	Reg.13-SEBI(Prohibition of Insider Trading Regulations)1992
Entity making the Disclosure	Ambuja Cements Limited

Name & Address of Director/Officer Date of receipt of allotment advice/acquisition / sale of shares/voting rights Date of intimation to company Mode of acquisition (market purchase/public/rights/preferential offer etc.) No. & % of shares/post acquisition/voting rights sale Buy Qty Sell Qty No. Type % Rajendra P. Anjaria 08-SEP-2010 09-SEP-2010 ESOP 3551 Equity 2000 Rameshchandra Darak 07-SEP-2010 09-SEP-2010 225000 Equity 0.016 15000 Remarks No. & % of shares/voting rights held by thr Director/Designated Employee & No. & % of shares /post acquisition/voting rights sale : Including Dependant Shareholdings

Short Description	Reg.13-SEBI(Prohibition of Insider Trading Regulations)1992
Entity making the Disclosure	Ambuja Cements Limited

Name & Address of Director/Officer Date of receipt of allotment advice/acquisition / sale of shares/voting rights Date of intimation to company Mode of acquisition (market purchase/public/rights/preferential offer etc.) No. & % of shares/post acquisition/voting rights sale Buy Qty Sell Qty No. Type % Suresh Joshi 06-SEP-2010 06-SEP-2010 ESOPS 37562 Equity 29500 Shri AL Kapur-Mg. Director 03-SEP-2010 06-SEP-2010 1173620 Equity 20000 Shri Ajay Kapur- Business Head Ambuja Cements Ltd 06-SEP-2010 59500 Equity 13000 Remarks Note: Shri Ajay Kapur-: Business Head Ambuja Cements Ltd- Date of Receipt of Allotment Advice/Acquisition/Sale of shares/voting rights-: On 26-AUG-2010- Sold-2000 Shares; On 30-AUG-2010-Sold-1000 Shares; On 31-AUG-2010- Sold 10000 Shares

Short Description	Reg.13-SEBI(Prohibition of Insider Trading Regulations)1992
Entity making the Disclosure	Ambuja Cements Limited

Name & Address of Director/Officer Date of receipt of allotment advice/acquisition / sale of shares/voting rights Date of intimation to company Mode of acquisition (market purchase/public/rights/preferential offer etc.) No. & % of shares/post acquisition/voting rights sale Buy Qty Sell Qty No. Type % Suresh Joshi 07-SEP-2010 07-SEP-2010 ESOPS 62 Equity 37500 Lalit P. Vaishnav 07-SEP-2010 07-SEP-2010 ESOS 39250 Equity 10000 B.L. Taparia 07-SEP-2010 08-SEP-2010 173750 Equity 0.012 10000 Arun Kumar Sarkar 07-SEP-2010 08-SEP-2010 ESOS Scheme 6415 Equity 6000

Short Description	Reg.13-SEBI(Prohibition of Insider Trading Regulations)1992
Entity making the Disclosure	Rameshchandra Darak

Name & Address of Director/Officer Date of receipt of allotment advice/acquisition / sale of shares/voting rights Date of intimation to company Mode of acquisition (market purchase/public/rights/preferential offer etc.) No. & % of shares/post acquisition/voting rights sale Buy Qty Sell Qty No. Type % Rameshchandra Darak- President-Accounts & IT 07-SEP-2010 09-SEP-2010 225000 Equity 0.016 15000 Remarks No. & % of shares/voting rights held by thr Director/Designated Employee & No. & % of shares /post acquisition/voting rights sale : Including Dependant Shareholdings

	Ang Industries Limited has informed the Exchange that the Board of Directors of the Company in their meeting held on September 09, 2010, has approved the following: (1) Allotment of 11,00,000 Convertible warrants on preferential basis; (2) The notice of postal ballot for approving the rectification of the resolution on preferential basis.
Attachment

Apollo Tyres Limited has informed the Exchange that : "The following facts relating to Apollo Tyres South Africa (Pty.) Ltd. (ATSA), a wholly-owned-subsidiary of Apollo Tyres Ltd. to your notice : (1) Consequent upon declaration of a General Strike in tyre industry in South Africa, the workers of both the plants at Durban and Ladysmith of ATSA have also gone on strike; (2) ATSA has received notice of a referral to the Competition Tribunal of a complaint by the Competition Commission dated 31.08.2010 alleging anti-competitive conduct by tyre manufactures, including ATSA and recommending imposition of an administrative penalty of 10% of turnover for the year 2008. We have been advised that ATSA have submitted all the information of the Competition Commission in a transparent manner during the course of enquiry and have fully co-operated with their investigation to date. ATSA is in process of defending the case at the level of Competition Tribunal by taking suitable legal advice".

Aqua Logistics Limited has informed the Exchange that Board of Directors of at their meeting held on September 09, 2010 has fixed October 04, 2010 as the "Record Date" for determining the eligibility of Shareholders eligible for getting the Sub-divided Equity Shares from Rs. 10 each to Re. 1/- each.

Short Description	Reg.13-SEBI(Prohibition of Insider Trading Regulations)1992
Entity making the Disclosure	Ashco Niulab Industries Limited

Name & address of shareholder No. and percentage of shares /voting rights acquired /sold Receipt of allotment advice/acquisition of shares/sale of shares ? specify Date of intimation to company Mode of acquisition (market purchase/public/rights/preferential offer etc.) No. & % of shares/voting rights post-acquisition/sale Buy Qty Sell Qty No. Type % No. % Ankush A. Kotwani 500000 Equity SALE OF SHARES 09-SEP-2010 15712936 2.42 500000 Remarks Note:- The Board of Directors of the Company allotted 337795000 underlying Equity Shares representing the GDRs. Hence the percentage has been taken as to the total number of shares after allotment which has become 649831000 Equity Shares.

Short Description	Reg.13-SEBI(Prohibition of Insider Trading Regulations)1992
Entity making the Disclosure	Ashco Niulab Industries Limited

Name & address of shareholder No. and percentage of shares /voting rights acquired /sold Receipt of allotment advice/acquisition of shares/sale of shares ? specify Date of intimation to company Mode of acquisition (market purchase/public/rights/preferential offer etc.) No. & % of shares/voting rights post-acquisition/sale Buy Qty Sell Qty No. Type % No. % Ankush A. Kotwani 784303 Equity 0.12 SALE OF SHARES 08-SEP-2010 16212936 2.49 784303 Remarks The Board of Directors of the Company allotted 337795000 underlying Equity Shares representing the GDRs. Hence the percentage has been taken as to the total number of shares after allotment which has become 649831000 Equity Shares.

	Aurobindo Pharma Limited has informed the Exchange regarding a press release dated September 09, 2010, titled "Aurobindo Pharma receives MCC South Africa approvals for 23 registrations".
Attachment

Short Description	Reg.13-SEBI(Prohibition of Insider Trading Regulations)1992
Entity making the Disclosure	Autoline Industries Limited

Name & address of shareholder No. and percentage of shares /voting rights acquired /sold Receipt of allotment advice/acquisition of shares/sale of shares ? specify Date of intimation to company Mode of acquisition (market purchase/public/rights/preferential offer etc.) No. & % of shares/voting rights post-acquisition/sale Buy Qty Sell Qty No. Type % No. % Duke Advisors Pvt Ltd. 37000 Equity 19-AUG-2010 03-SEP-2010 Market Trade 508950 37000 Duke Advisors Pvt Ltd. 8250 Equity 19-AUG-2010 03-SEP-2010 Market Trade 517200 8250 TS India Holding LLC 3900 Equity 17-AUG-2010 03-SEP-2010 Market Trade 418243 3900 TS India Holding LLC 20627 Equity 18-AUG-2010 03-SEP-2010 Market Trade 397616 20627 TS India Holding LLC 40000 Equity 19-AUG-2010 03-SEP-2010 Market Trade 357616 40000 TS India Holding LLC 30000 Equity 20-AUG-2010 03-SEP-2010 Market Trade 327616 30000

Aventis Pharma Limited has informed the Exchange that the following changes have taken place in the Board of Directors of the Company : (1) Mr. M. Dargentolle, Chief Financial Officer of the Company who was Alternate Director to Mr. O. Charmeil has been appointed a Director of the Company with effect from July 19, 2010; (2) Mr. J. M. Georges, Director, Industrial Pharma Intercontinental of the sanofi-aventis Group and Mr. F. X. Duhalde, Director - Finance & Administration of the sanofi-aventis Group, have been appointed as Additional Directors of the Company with effect from July 29, 2010.

Attachment

Aventis Pharma Limited has informed the Exchange that the following changes have taken place in the Board of Directors of the Company : (1) Mr. M. Dargentolle, Chief Financial Officer of the Company who was Alternate Director to Mr. O. Charmeil has been appointed a Director of the Company with effect from July 19, 2010; (2) Mr. J. M. Georges, Director, Industrial Pharma Intercontinental of the sanofi-aventis Group and Mr. F. X. Duhalde, Director - Finance & Administration of the sanofi-aventis Group, have been appointed as Additional Directors of the Company with effect from July 29, 2010.

Attachment

Aventis Pharma Limited has informed the Exchange that the following changes have taken place in the Board of Directors of the Company : (1) Mr. M. Dargentolle, Chief Financial Officer of the Company who was Alternate Director to Mr. O. Charmeil has been appointed a Director of the Company with effect from July 19, 2010; (2) Mr. J. M. Georges, Director, Industrial Pharma Intercontinental of the sanofi-aventis Group and Mr. F. X. Duhalde, Director - Finance & Administration of the sanofi-aventis Group, have been appointed as Additional Directors of the Company with effect from July 29, 2010.

Attachment

Short Description	Disc under Reg Subs Acq &Takeover & SEBI Insider Trading Reg
Entity making the Disclosure	Bajaj Auto Finance Limited

Name of the Target Company Bajaj Auto Finance Ltd Name of the acquirers/sellers and PACs with them Bajaj Finserv Limited Date of Acquisition/sale 07-SEP-2010 Mode of acquisition (e.g. open market / public issue / rights issue / preferential allotment / interse transfer etc.) Open Market Mode of sale (e.g. open market/MOU/off market, etc.) Particulars of acquisition/sale Number Type % w.r.t. total paid up capital of Target Company Shares/Voting rights (VR) before acquisition under consideration 18500699 Equity 50.55 Shares/voting rights acquired 1601900 Equity 4.38 Shares/VR after acquisition 20102599 Equity 54.93

Short Description	Disc under Reg Subs Acq &Takeover & SEBI Insider Trading Reg
Entity making the Disclosure	Bajaj Auto Finance Limited

Name of the Target Company Bajaj Auto Finance Ltd Name of the acquirers/sellers and PACs with them Copa Cabana Date of Acquisition/sale 07-SEP-2010 Mode of acquisition (e.g. open market / public issue / rights issue / preferential allotment / interse transfer etc.) Mode of sale (e.g. open market/MOU/off market, etc.) Open Market Particulars of acquisition/sale Number Type % w.r.t. total paid up capital of Target Company Shares/Voting rights (VR) before acquisition under consideration 3314870 Equity 9.06 Shares/voting rights acquired 1611250 Equity 4.4 Shares/VR after acquisition 1703620 Equity 4.66